An Assessment of Short-Acting Hypnotics

  title={An Assessment of Short-Acting Hypnotics},
  author={W. Mendelson and B. Jain},
  journal={Drug Safety},
  • W. Mendelson, B. Jain
  • Published 1995
  • Medicine
  • Drug Safety
  • SummaryInsomnia, the experience of poor quality or quantity of sleep, is a very common complaint. Approximately 65 million adults (36% of the American population) complain of poor sleep, and of this group, 25% have insomnia on a chronic basis. These chronic insomniacs not only report higher rates of difficulty with concentration, memory and the ability to cope with minor irritations but also have 2.5 times more fatigue-related automobile accidents than do good sleepers. Despite its ubiquity… CONTINUE READING
    57 Citations
    Non-benzodiazepines for the treatment of insomnia.
    • 103
    The effects of substituting zopiclone in withdrawal from chronic use of benzodiazepine hypnotics
    • 19
    Secondary insomnia: diagnostic challenges and intervention opportunities.
    • 88
    • PDF
    The Pharmacology and Mechanism of Action of Zolpidem.
    • 42
    • PDF
    Hypnotics and sedatives
    Sleep Disorders in the Elderly
    • 50
    Psychological treatment of secondary insomnia.
    • 178
    • PDF
    Pharmacodynamic profile of Zaleplon, a new non‐benzodiazepine hypnotic agent
    • 44
    Insomnia in General Practice
    • 8


    A Sleep Laboratory Evaluation of the Long-Term Efficacy of Zopiclone
    • 35
    Effects of zopiclone on the sleep of chronic insomniacs.
    • 21
    Efficacy of a reduced triazolam dose in elderly insomniacs
    • 44
    Long term efficacy and withdrawal of zopiclone: a sleep laboratory study.
    • 33
    Issues in the use of benzodiazepine therapy.
    • 88
    Rebound insomnia: duration of use and individual differences.
    • 22